NCT03859024View on ClinicalTrials.gov

Efficacy of Opioid-limiting Pain Management Protocol in Men Undergoing Urethroplasty

PHASE4CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

March 22, 2019

Primary Completion Date

April 30, 2023

Study Completion Date

June 30, 2023

Conditions
Pain, PostoperativeUrethral Stricture
Interventions
DRUG

Oxycodone

oxycodone tablet

DRUG

Acetaminophen

acetaminophen tablet

DRUG

Gabapentin

gabapentin tablet

DRUG

celebrex

Celebrex tablet

DRUG

Bupivacaine

bupivacaine injection

DRUG

Ibuprofen 800 mg

ibuprofen tablet

DRUG

Dexamethasone

Dexamethasone injection

Trial Locations (1)

35233

University of Alabama of Birmingham, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER

NCT03859024 - Efficacy of Opioid-limiting Pain Management Protocol in Men Undergoing Urethroplasty | Biotech Hunter | Biotech Hunter